Fresenius Kabi is a pioneer in Parenteral Nutrition (PN). We are proud to leverage our heritage of innovation to support the advancement of parenteral nutrition for critically ill and chronically ill patients.
Fresenius Kabi introduced the very first commercially available lipid injectable emulsion (ILE) in 1962, was the first to introduce a four-oil blend ILE, and was also the first to bring a 100% fish-oil ILE to market.
An innovative global market leader
As part of a leading international healthcare company consistently recognized as the global market leader in PN, Fresenius Kabi Canada offers a comprehensive portfolio of products in clinical nutrition for adults. Our products are used to help care for patients in hospitals, long-term care facilities, and at home.